human recombinant cd63 Search Results


N/A
Manufactured by Sino Biological (China); Distributed by Life Technologies. Cluster of Differentiation 63 (CD63) recombinant human protein is supplied as a lyophilized powder. This protein is suitable for use in analysis of protein structure. In
  Buy from Supplier


91
OriGene cd63
( a ) Different methods of EV isolation can be directly compared to assess yield and purity by measuring the three tetraspanins (CD9, <t>CD63,</t> and CD81) and albumin. ( b ) Single immuno-complexes are formed by binding the target tetraspanin protein on EVs to a magnetic bead conjugated to a capture antibody and a biotin-labeled detection antibody. Detection antibodies are labeled with a streptavidin-conjugated enzyme. The beads are then loaded into individual wells of a microwell array where each well matches the size of the magnetic bead limiting a maximum of one bead per well. Wells with the full immuno-complex (on wells) produce a fluorescent signal upon conversion of substrate, unlike wells with beads lacking the immuno-complex (off wells”). ( c ) EV and free proteins such as albumin in a biofluid sample are separated by SEC. Free proteins elute from the column in later fractions than EVs because free proteins are smaller than the pore size of the beads while EVs are larger and are excluded from entering the beads. EV, extracellular vesicle.
Cd63, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+recombinant+cd63/pmc08651285-14-4-6?v=OriGene
Average 91 stars, based on 1 article reviews
cd63 - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

90
Novus Biologicals recombinant human cd63 protein
( a ) Different methods of EV isolation can be directly compared to assess yield and purity by measuring the three tetraspanins (CD9, <t>CD63,</t> and CD81) and albumin. ( b ) Single immuno-complexes are formed by binding the target tetraspanin protein on EVs to a magnetic bead conjugated to a capture antibody and a biotin-labeled detection antibody. Detection antibodies are labeled with a streptavidin-conjugated enzyme. The beads are then loaded into individual wells of a microwell array where each well matches the size of the magnetic bead limiting a maximum of one bead per well. Wells with the full immuno-complex (on wells) produce a fluorescent signal upon conversion of substrate, unlike wells with beads lacking the immuno-complex (off wells”). ( c ) EV and free proteins such as albumin in a biofluid sample are separated by SEC. Free proteins elute from the column in later fractions than EVs because free proteins are smaller than the pore size of the beads while EVs are larger and are excluded from entering the beads. EV, extracellular vesicle.
Recombinant Human Cd63 Protein, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+recombinant+cd63/pmc05705088-43-0-7?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
recombinant human cd63 protein - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

85
Creative BioMart recombinant human cd63
( a ) Different methods of EV isolation can be directly compared to assess yield and purity by measuring the three tetraspanins (CD9, <t>CD63,</t> and CD81) and albumin. ( b ) Single immuno-complexes are formed by binding the target tetraspanin protein on EVs to a magnetic bead conjugated to a capture antibody and a biotin-labeled detection antibody. Detection antibodies are labeled with a streptavidin-conjugated enzyme. The beads are then loaded into individual wells of a microwell array where each well matches the size of the magnetic bead limiting a maximum of one bead per well. Wells with the full immuno-complex (on wells) produce a fluorescent signal upon conversion of substrate, unlike wells with beads lacking the immuno-complex (off wells”). ( c ) EV and free proteins such as albumin in a biofluid sample are separated by SEC. Free proteins elute from the column in later fractions than EVs because free proteins are smaller than the pore size of the beads while EVs are larger and are excluded from entering the beads. EV, extracellular vesicle.
Recombinant Human Cd63, supplied by Creative BioMart, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+recombinant+cd63/10__1158_slash_1535___7163__mct___16___0364-57-4-7?v=Creative+BioMart
Average 85 stars, based on 1 article reviews
recombinant human cd63 - by Bioz Stars, 2026-08
85/100 stars
  Buy from Supplier


N/A
Recombinant Human CD63 Fc Chimera Protein, CF
  Buy from Supplier

N/A
There are more than 320 CD unique clusters and subclusters have been identified. Some of the CD molecules serve as receptors or ligands important to the cell through initiating a signal cascade which then alter
  Buy from Supplier


N/A
Recombinant Human CD63
  Buy from Supplier

Image Search Results


( a ) Different methods of EV isolation can be directly compared to assess yield and purity by measuring the three tetraspanins (CD9, CD63, and CD81) and albumin. ( b ) Single immuno-complexes are formed by binding the target tetraspanin protein on EVs to a magnetic bead conjugated to a capture antibody and a biotin-labeled detection antibody. Detection antibodies are labeled with a streptavidin-conjugated enzyme. The beads are then loaded into individual wells of a microwell array where each well matches the size of the magnetic bead limiting a maximum of one bead per well. Wells with the full immuno-complex (on wells) produce a fluorescent signal upon conversion of substrate, unlike wells with beads lacking the immuno-complex (off wells”). ( c ) EV and free proteins such as albumin in a biofluid sample are separated by SEC. Free proteins elute from the column in later fractions than EVs because free proteins are smaller than the pore size of the beads while EVs are larger and are excluded from entering the beads. EV, extracellular vesicle.

Journal: eLife

Article Title: Framework for rapid comparison of extracellular vesicle isolation methods

doi: 10.7554/eLife.70725

Figure Lengend Snippet: ( a ) Different methods of EV isolation can be directly compared to assess yield and purity by measuring the three tetraspanins (CD9, CD63, and CD81) and albumin. ( b ) Single immuno-complexes are formed by binding the target tetraspanin protein on EVs to a magnetic bead conjugated to a capture antibody and a biotin-labeled detection antibody. Detection antibodies are labeled with a streptavidin-conjugated enzyme. The beads are then loaded into individual wells of a microwell array where each well matches the size of the magnetic bead limiting a maximum of one bead per well. Wells with the full immuno-complex (on wells) produce a fluorescent signal upon conversion of substrate, unlike wells with beads lacking the immuno-complex (off wells”). ( c ) EV and free proteins such as albumin in a biofluid sample are separated by SEC. Free proteins elute from the column in later fractions than EVs because free proteins are smaller than the pore size of the beads while EVs are larger and are excluded from entering the beads. EV, extracellular vesicle.

Article Snippet: Peptide, recombinant protein , CD63 , Origene , Cat# TP301733 , .

Techniques: Isolation, Binding Assay, Labeling, Pore Size

Simoa was performed to determine levels of CD9, CD63, CD81, and albumin after fractionating different volumes of plasma by SEC using a 10 mL Sepharose CL-6B column. Effect of sample volume on EV recovery and purity by SEC for ( a ) 0.1 ml, ( b ) 0.5 ml, ( c ) 1.0 ml. EV, extracellular vesicle; SEC, size exclusion chromatography; Simoa single-molecule array.

Journal: eLife

Article Title: Framework for rapid comparison of extracellular vesicle isolation methods

doi: 10.7554/eLife.70725

Figure Lengend Snippet: Simoa was performed to determine levels of CD9, CD63, CD81, and albumin after fractionating different volumes of plasma by SEC using a 10 mL Sepharose CL-6B column. Effect of sample volume on EV recovery and purity by SEC for ( a ) 0.1 ml, ( b ) 0.5 ml, ( c ) 1.0 ml. EV, extracellular vesicle; SEC, size exclusion chromatography; Simoa single-molecule array.

Article Snippet: Peptide, recombinant protein , CD63 , Origene , Cat# TP301733 , .

Techniques: Clinical Proteomics, Size-exclusion Chromatography

Simoa was performed to determine levels of CD9, CD63, CD81, and albumin after fractionating different volumes of CSF by SEC using a 10-ml Sepharose CL-6B column. Effect of sample volume on EV recovery and purity by SEC for ( a ) 0.1 ml, ( b ) 0.5 ml, ( c ) 1.0 ml. CSF, cerebrospinal fluid; EV, extracellular vesicle; SEC, size exclusion chromatography; Simoa, single-molecule array.

Journal: eLife

Article Title: Framework for rapid comparison of extracellular vesicle isolation methods

doi: 10.7554/eLife.70725

Figure Lengend Snippet: Simoa was performed to determine levels of CD9, CD63, CD81, and albumin after fractionating different volumes of CSF by SEC using a 10-ml Sepharose CL-6B column. Effect of sample volume on EV recovery and purity by SEC for ( a ) 0.1 ml, ( b ) 0.5 ml, ( c ) 1.0 ml. CSF, cerebrospinal fluid; EV, extracellular vesicle; SEC, size exclusion chromatography; Simoa, single-molecule array.

Article Snippet: Peptide, recombinant protein , CD63 , Origene , Cat# TP301733 , .

Techniques: Size-exclusion Chromatography

Journal: eLife

Article Title: Framework for rapid comparison of extracellular vesicle isolation methods

doi: 10.7554/eLife.70725

Figure Lengend Snippet:

Article Snippet: Peptide, recombinant protein , CD63 , Origene , Cat# TP301733 , .

Techniques: Clinical Proteomics, Biomarker Discovery, Enzyme-linked Immunosorbent Assay, Recombinant, Isolation